Skip to content

Clinical trials

Diabetic Nephropathies trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Nephropathies Country / region: South Korea Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20101
20123
20135
20142
20152
20191
20213
20221
20232
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Unknown status3
Recruiting2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer3
AstraZeneca2
Boehringer Ingelheim2
Dong Wha Pharmaceutical Co. Ltd.2
Pfizer2
Seoul National University Hospital2
Alexion Pharmaceuticals, Inc.1
Aptabio Therapeutics, Inc.1
Asia Diabetes Foundation1
Boryung Pharmaceutical Co., Ltd1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Nephropathies24
Diabetes Mellitus, Type 25
Renal Insufficiency, Chronic5
Glomerulonephritis, IGA3
Hypertension3
Glomerulosclerosis, Focal Segmental2
Kidney Diseases2
Nephrosis, Lipoid2
Proteinuria2
Albuminuria1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.